M&G Investments has invested $75 million in Biobest, a pollination and integrated biological pest and disease control solution provider.
M&G’s £5 billion Catalyst strategy, focusing on purpose-led flexible private assets, aims to invest in companies transitioning to positive and regenerative practices, aligning with Biobest’s mission.
This strategic investment positions Biobest to enhance its biological solutions portfolio, contributing to sustainable agriculture practices globally. The investment will support Biobest’s acquisition of Biotrop, a Brazilian biological solutions specialist, enabling it to become a major player in South America.
Niranjan Sirdeshpande, global head of investments, M&G Catalyst, will join Biobest’s board as a non-executive director. He commented: “It is now more important than ever to accelerate the transition to sustainable solutions in agriculture.”
Jean-Marc Vandoorne, CEO of Biobest, said: “Aligning with M&G’s Catalyst strategy, this milestone investment allows for Biobest to expand in this fast-developing domain, driving sustainability and profits.“
© 2024 funds europe
